Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine

References

• GBD Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis. 2017;17(9):909–48. doi:10.1016/S1473-3099(17)30276-1. PMID: 28579426.
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization–Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013. PMID: 27059362.
   PubMed Web of Science ®Google Scholar
• Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–65. doi:10.1001/jamapediatrics.2018.1960. PMID: 30105384.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). WHO prequalifies new rotavirus vaccine. Geneva (Switzerland): WHO; 2018 Oct 1 [accessed 2019 May 23]. https://www.who.int/medicines/news/2018/prequalified_new-rotavirus_vaccine/en/.
   Google Scholar
• Bharat Biotech. World Health Organization grants prequalification to Bharat Biotech’s rotavirus vaccine, ROTAVAC®. Hyderabad (India): Bharat Biotech; 2018 Jan 24 [accessed 2019 May 23]. https://www.bharatbiotech.com/images/press/Bharat_Biotech_2018_pressrelease2.pdf.
   Google Scholar
• Dang DA, Nguyen VT, Vu DT, Nguyen TH, Nguyen DM, Yuhuan W, Baoming J, Nguyen DH, Le TL, Rotavin-M1 Vaccine Trial Group. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine. 2012;30(Suppl 1):A114–A121. doi:10.1016/j.vaccine.2011.07.118. PMID: 22520120.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Yang Y, Liang Z, Tian Y, Liu B, Gao Z, Jia L, Chen L, Wang Q. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age. Vaccine. 2019;37(27):3611–16. doi:10.1016/j.vaccine.2019.03.069. PMID: 31122857.
   PubMed Web of Science ®Google Scholar
• Desselberger U. Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors. Pathogens. 2017;6(4):E65. doi:10.3390/pathogens6040065. PMID: 29231855.
   PubMed Web of Science ®Google Scholar
• Parker EPK, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 2018;13:97–118. doi:10.2217/fmb-2017-0128. PMID: 29218997.
   PubMed Web of Science ®Google Scholar
• Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, Liu J, Houpt E, Iturriza-Gómara M, Kampmann B, et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine. 2018;36(2):264–72. doi:10.1016/j.vaccine.2017.11.031. PMID: 29217369.
   PubMed Web of Science ®Google Scholar
• Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines. 2018;17(2):145–61. doi:10.1080/14760584.2018.1418665. PMID: 29252042.
   PubMed Web of Science ®Google Scholar
• Harris VC, Armah G, Fuentes S, Korpel KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J Infect Dis. 2017;215(1):34–41. doi:10.1093/infdis/jiw518. PMID: 27803175.
   PubMed Web of Science ®Google Scholar
• Wen X, Cao D, Jones RW, Li J, Szu S, Hoshino Y. Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates. Vaccine. 2012;30(43):6121–26. doi:10.1016/j.vaccine.2012.07.078. PMCID: PMC3434302.
   PubMed Web of Science ®Google Scholar
• Wen X, Cao D, Jones RW, Hoshino Y, Yuan L. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic. Hum Vaccin Immunother. 2015;11(10):2483–89. doi:10.1080/21645515.2015.1054583. PMCID: PMC4635725.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2017:S0264-410X(17)30410–3. doi:10.1016/j.vaccine.2017.03.076. PMID: 28396207.
   Web of Science ®Google Scholar
• Estes MK, Greenburg HB. Rotaviruses. In: Knipe DM, Howley PM editors. Fields virology. 6th. Philadelphia (PA): Lippincott, Williams & Wilkins; 2013. p. 1347–401.
   Google Scholar
• Hu L, Crawford SE, Hyser JM, Estes MK, Prasad BV. Rotavirus non-structural proteins: structure and function. Curr Opin Virol. 2012;2(4):380–88. doi:10.1016/j.coviro.2012.06.003. PMID: 22789743.
   PubMed Web of Science ®Google Scholar
• Ruggeri FM, Greenberg HB. Antibodies to the trypsin cleavage peptide VP8* neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol. 1991;65(5):2211–19. PMID: 1850007.
   PubMed Web of Science ®Google Scholar
• Heylen E, Zeller M, Ciarlet M, Lawrence J, Steele D, Van Ranst M, Matthijnssens J. Human P[6] rotaviruses from sub-Saharan Africa and southeast Asia are closely related to those of human P[4] and P[8] rotaviruses circulating worldwide. J Infect Dis. 2016;214(7):1039–49. doi:10.1093/infdis/jiw247. PMID: 27471320.
   PubMed Web of Science ®Google Scholar
• Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15(1):29–56. doi:10.1002/rmv.448. PMID: 15484186.
   PubMed Web of Science ®Google Scholar
• Wen X, Wen K, Cao D, Li G, Jones RW, Li J, Szu S, Hoshino Y, Yuan L. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus DeltaVP8*subunit parenteral vaccines. Vaccine. 2014;32(35):4420–27. doi:10.1016/j.vaccine.2014.06.060. PMID: 27471320.
   PubMed Web of Science ®Google Scholar
• Gołoś A, Lutyńska A. Aluminium-adjuvanted vaccines–a review of the current state of knowledge. Przegl Epidemiol. 2015;69(4):731–34. PMID: 27139352.
   PubMedGoogle Scholar
• Fix AD, Harro C, McNeal M, Dally L, Flores J, Robertson G, Boslego JW, Cryz S. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine. 2015;33(31):3766–72. doi:10.1016/j.vaccine.2015.05.024. PMID: 26065919.
   PubMed Web of Science ®Google Scholar
• Hansen B, Sokolovska A, HogenEsch H, Hem SL. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine. 2007;25(36):6618–24. doi:10.1016/j.vaccine.2007.06.049. PMID: 17681647.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Rost BE. Aluminum compounds as vaccine adjuvants. In: O’Hagan DT editor. Vaccine adjuvants: preparation methods and research protocols. Vol. 42. Totowa (NJ): Humana Press; 2000. p. 65–89.
   Google Scholar
• National Institutes of Health, Office of Laboratory Animal Welfare. Public health service policy on humane care and use of laboratory animals. Bethseda (MD): US Department of Health and Human Services; 2015 [accessed 2019 May 23]. https://olaw.nih.gov/policies-laws/phs-policy.htm
   Google Scholar
• National Research Council. Guide for the care and use of laboratory animals. Washington (DC): The National Academies Press; 1996 Jul [accessed 2019 May 23]. https://www.nap.edu/catalog/5140/guide-for-the-care-and-use-of-laboratory-animals.
   Google Scholar
• Palombo EA, Bishop RF. Genetic analysis of NSP1 genes of human rotaviruses isolated from neonates with asymptomatic infection. J Gen Virol. 1994;75(Pt12):3635–39. doi:10.1099/0022-1317-75-12-3635. PMID: 7996158.
   PubMedGoogle Scholar
• Knowlton DR, Spector DM, Ward RL. Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods. 1991;33(1–2):127–34. doi:10.1016/0166-0934(91)90013-P. PMID: 1658027.
   PubMed Web of Science ®Google Scholar
• Fetzer TJ, Mans C. Jejuno-jejunal intussusception in a guinea pig (Cavia porcellus). Open Vet J. 2017;7(3):286–89. doi:10.4314/ovj.v7i3.14. PMID: 29038782.
   PubMed Web of Science ®Google Scholar
• Seeber SJ, White JL, Hem SL. Predicting the adsorption of proteins by aluminium-containing adjuvants. Vaccine. 1991;9(3):201–03. doi:10.1016/0264-410X(91)90154-X. PMID: 2042392.
   PubMed Web of Science ®Google Scholar
• Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem. 2005;280(14):13406–134014. doi:10.1074/jbc.M500687200. PMID: 15684430.
   PubMed Web of Science ®Google Scholar
• Watkinson A, Soliakov A, Ganesan A, Hirst K, Lebutt C, Fleetwood K, Fusco PC, Fuerst TR, Lakey JH. Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactions. Clin Vaccine Immunol. 2013;20(11):1659–68. doi:10.1128/CVI.00320-13. PMID: 23986317.
   PubMedGoogle Scholar
• Wen X, Wei X, Ran X, Ni H, Cao S, Zhang Y. Immunogenicity of porcine P[6], P[7]-specific △VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope. Vaccine. 2015;33(56):4533–39. doi:10.1016/j.vaccine.2015.07.011. PMID: 26192360.
   PubMedGoogle Scholar
• Groome MJ, Koen A, Fix A, Page N, Jose L, Madhi SA, McNeal M, Dally L, Cho I, Power M, et al. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomized, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17(8):843–53. doi:10.1016/S1473-3099(17)30242-6. PMID: 28483414.
   PubMed Web of Science ®Google Scholar
• Westerman LE, McClure HM, Jiang B, Almond JW, Glass RI. Serum IgG mediates mucosal immunity against rotavirus infection. Proc Natl Acad Sci USA. 2005;102(20):7268–73. doi:10.1073/pnas.0502437102. PMID: 15883382.
   PubMed Web of Science ®Google Scholar
• Resch TK, Wang Y, Moon SS, Joyce J, Li S, Prausnitz M, Jiang B. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice. Sci Rep. 2018;8(1):561. doi:10.1038/s41598-017-18973-9. PMID: 29330512.
   PubMedGoogle Scholar
• Agarwal S, Hickey JM, McAdams D, White JA, Sitrin R, Khandke L, Cryz S, Joshi SB, Volkin DB. Effect of aluminum adjuvant and preservatives on structural integrity and physicochemical stability profiles of three recombinant subunit rotavirus vaccine antigens. J Pharm Sci. 2019:S0022-3549(19)30638–0. doi:10.1016/j.xphs.2019.10.004. PMID: 31589875.
   Web of Science ®Google Scholar
• Agarwal S, Sahni N, Hickey JM, Robertson GA, Sitrin R, Cryz S, Joshi SB, Volkin DB. Characterizing and minimizing aggregation and particle formation of three recombinant fusion-protein bulk antigens for use in a candidate trivalent rotavirus vaccine. J Pharm Sci. 2019:S0022-3549(19)30494–0. doi:10.1016/j.xphs.2019.08.001. PMID: 31400346.
   Web of Science ®Google Scholar